Glycostem Chief Development Officer Volker Huppert is going to chair a discussion at the BioProcess International Europe (BPI) 2023 in Amsterdam.

NK Cell Manufacturing: In Process Controls in a Scalable Manufacturing Process

Date and Time: Thursday, 11 May 2023 11:30 - 12:00 CET

Track: Cell & Gene Therapy
 

Glycostem is going to present a poster regarding CD19 CAR-NK and CD16 ADCC during the 20th CIMT Annual Meeting in Mainz, Germany.

Date: 3 May 2023

Present by: Nina Lamers-Kok, Research Scientist and Didem Özkazanc, Research Specialist

Glycostem Senior Research Manager Monica Raimo is going to participate Asia Bio Partnering Forum during 26 April to 27 April in Singapore. 

Glycostem Chief Scientific Officer Jan Spanholtz is going to present at the EBMT 2023 in Paris.

Session title:       Multi-stakeholder Forum on Innovative Cellular Therapies II - Hospital Exemption
Session room:       Room 143
Date/Time:       26 April 2023, 10:30 – 11:45 CET 
TITLE OF LECTURE:    NK cell based therapies - Pharma perspective on challenges and opportunities

Glycostem is going to participate Innate Killer Summit 2023, taken place on 28 - 30 March 2023 in San Diego, US.

Tuesday, 28 March 28 2023 

8:30 PDT Workshop: Carrying out the Preclinical Evaluation of Off-the-Shelf NK Cell Therapy for the
Treatment of Solid and Heme Malignancies

Adil Duru, Senior Research Manager, Glycostem

Wednesday, 29 March 2023

8:15 PDT Industry Leader’s Annual Briefing: Reviewing the Innate Killer Landscape, & Setting Industry Goals for
2023 & Beyond

Troels Jordansen, CEO, Glycostem

15:15 Driving GMP Readiness with Scalable Manufacturing Platforms & Second Sourcing Strategies with GMP Materials

Troels Jordansen, CEO, Glycostem

Glycostem CEO Troels Jordansen is going to participate Bio-Europe Spring 2023.

The seventeenth annual BIO-Europe Spring® premier springtime partnering conference is back in-person and will be taking place  20–22 March, 2023 in Basel, Switzerland.